|
304
|
Afp down + zwduur
Panel
|
|
Serum |
|
43 (1,8) |
–
|
—
|
—
|
› |
|
351
|
RhD-moleculair
Panel
|
|
EDTA |
|
166 (6,9) |
–
|
—
|
—
|
› |
|
903
|
FSH (M/V)
|
|
Serum |
|
|
–
|
—
U/L |
—
|
› |
|
1254
|
alfa 1 glycoproteine
✉
|
|
Serum |
2x per week |
|
–
|
—
µg/mL |
—
g/L |
› |
|
1270
|
Factor II dosage
✉
|
|
Citraat |
1x per 2 weken |
|
–
|
3289-6
% |
—
|
› |
|
1272
|
Factor V dosage
✉
|
|
Citraat |
Tenminste 1x per week |
218 (9,1) |
–
|
3193-0
% |
—
|
› |
|
1274
|
Factor VII dosage
✉
Proconvertine
|
|
Citraat |
1x per 2 weken |
521 (21,7) |
–
|
3198-9
% |
—
|
› |
|
1280
|
Factor VIII (dier)
✉
|
|
Citraat |
Minder dan éénmaal per maand |
3 (0,1) |
–
|
—
% |
—
|
› |
|
1281
|
von Willebrand (dier)
✉
Factor VIII gerelateerd antigen, Von Willebrand antigen, vWF Ag
|
|
Citraat |
|
3 (0,1) |
–
|
—
% |
—
|
› |
|
1292
|
Factor XI dosage
✉
|
|
Citraat |
1x per 2 weken |
422 (17,6) |
–
|
3226-8
% |
—
|
› |
|
1294
|
Factor XII dosage
✉
Hageman Factor
|
|
Citraat |
|
|
–
|
3232-6
% |
—
|
› |
|
1296
|
Factor XIII screening
✉
|
|
Citraat |
|
|
–
|
3239-1
|
—
|
› |
|
1313
|
Antithrombine (dier)
✉
|
|
Citraat |
Maandag t/m vrijdag |
67 (2,8) |
–
|
—
% |
—
|
› |
|
1342
|
anti-factor Xa
✉
|
|
Citraat |
1x per week |
96 (4) |
–
|
3216-9
IU/ml |
—
|
› |
|
1343
|
anti-Xa Rivaroxaban
✉
Anti-Xa (New Oral AntiCoagulants)
|
|
Citraat |
1x per week |
|
–
|
74871-5
ng/mL |
—
|
› |
|
1344
|
Anti-Xa Apixaban
✉
|
|
Citraat |
Dagelijks |
18 (0,7) |
–
|
74214-8
ng/mL |
—
|
› |
|
1350
|
Plaatjesfunctie
Panel
|
|
|
|
|
–
|
—
|
—
|
› |
|
1369
|
Bloedgroep + D (BTCA)
Panel
|
|
EDTA |
|
87 (3,6) |
–
|
—
|
—
|
› |
|
1403
|
LUTHERAN
Panel
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1404
|
Heredit. hemochromatose
✉
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1423
|
Kp b antigeen (KEL4)
✉
|
|
EDTA |
|
|
–
|
1108-0
|
—
|
› |
|
1424
|
Coombs-test
✉
|
|
EDTA |
|
70 (2,9) |
–
|
—
|
—
|
› |
|
1427
|
Parathormoon (dier)
✉
Parathyeoïdhormoon, PTH
|
|
EDTA |
|
440 (18,3) |
–
|
—
pg/ml |
—
pmol/L |
› |
|
1428
|
Parathormoon rp (dier)
✉
Parathyeoïdhormoon gerelateerd peptide, PTH related Peptide, PTH Rp
|
|
EDTA |
|
570 (23,7) |
–
|
—
pmol/l |
—
|
› |
|
1448
|
Heredit. hemochromatose
✉
Haemochromatose gen, Hemochromatose gen, HFE1
|
|
EDTA |
|
544 (22,7) |
–
|
—
|
—
|
› |
|
1449
|
Mucoviscidose
✉
CF, CFTR, Cystic Fibrosis Transmembrane conductance Regulator-gen
|
|
EDTA |
|
724 (30,1) |
–
|
—
|
—
|
› |
|
1451
|
Fragile X syndroom
✉
FMR1, Fragile X Mental Retardation 1-gen
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1459
|
HLA-DQB1/DRB1 (narcolep)
✉
|
|
EDTA |
1x per 2 weken |
|
–
|
—
|
—
|
› |
|
1475
|
DNA onderzoek A'pen
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
6 (0,3) |
–
|
—
|
—
|
› |
|
1476
|
DNA onderzoek Leuven
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
5 (0,2) |
–
|
—
|
—
|
› |
|
1477
|
DNA onderzoek VUB
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
522 (21,8) |
–
|
—
|
—
|
› |
|
1478
|
DNA-onderzoek Gent
Panel
|
|
Heparine (Lithium-heparinebuis) |
|
|
–
|
—
|
—
|
› |
|
1518
|
Moleculaire bepaling RHCE
Panel
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1550
|
Fertiliteit
Panel
Fertiliteitsonderzoek, Semen-onderzoek, Telling-Motiliteit-Morfologie
|
|
Sperma (Semen) |
|
197 (8,2) |
–
|
—
|
—
|
› |
|
1553
|
Vitaalkleuring
Panel
|
|
Sperma (Semen) |
|
8 (0,3) |
–
|
—
|
—
|
› |
|
1555
|
Morfologie
Panel
|
|
Sperma (Semen) |
|
197 (8,2) |
–
|
9704-8
|
—
|
› |
|
1556
|
Na vasectomie
Panel
Semen-onderzoek postvasectomie
|
|
Sperma (Semen) |
|
18 (0,8) |
–
|
—
|
—
|
› |
|
1575
|
Voor capacitatie (AML)
Panel
Semen-onderzoek voor proefcapacitatie
|
|
Sperma (Semen) |
|
127 (5,3) |
–
|
—
|
—
|
› |
|
1577
|
Na proefcapacitatie (AML)
Panel
Semen-onderzoek na proefcapacitatie
|
|
Sperma (Semen) |
|
199 (8,3) |
–
|
—
|
—
|
› |
|
1620
|
Erythrocyten antistoffen
Panel
Erythrocyten antistoffen - BTCA, Irreguliere antistoffen (identificatie), Rode bloedcel antistoffen - BTCA
|
|
Serum, EDTA |
|
124 (5,2) |
–
|
—
|
—
|
› |
|
1630
|
Identificatie BTCA
Panel
DAT, DCT, Directe Coombs - BTCA
|
|
EDTA |
|
47 (2) |
–
|
—
|
—
|
› |
|
1640
|
Elueren RBC antistof BTCA
Panel
Elueren erythrocyten antistoffen - BTCA
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
1680
|
Gluc-6-fosf.DH in RBC
✉
G6PD intraerythrocytair, Glucose-6-fosfaat dehydrogenase intraerythrocytair
|
|
EDTA |
Tenminste 1x per week |
119 (4,9) |
–
|
2357-2
U/ml ery |
—
|
› |
|
1683
|
JAK2 V617F mutatie
✉
JAK2 mutatie, JAK2 mutation
|
|
EDTA |
1x per week |
424 (17,7) |
–
|
—
|
—
|
› |
|
1684
|
Pyruvaatkinase in RBC
✉
Pyruvaatkinase intraerythrocytair
|
|
EDTA |
|
459 (19,1) |
–
|
32552-2
U/g Hb |
—
|
› |
|
1712
|
MPN panel (12 genen)
✉
|
|
EDTA |
1x per week |
|
–
|
—
|
—
|
› |
|
1770
|
Immunofenotypering
Panel
Lymfocyten fenotypering
|
|
EDTA |
|
75 (3,1) |
–
|
—
|
—
|
› |
|
1779
|
Flowcytometrie ikv
✉
Immunofenotypering, Lymfocyten fenotypering
|
|
EDTA |
|
1 (0) |
–
|
—
|
—
|
› |
|
1960
|
PNH onderzoek
Panel
FLAER expressie, Immunofenotypering (paroxysmale nachtelijke hemoglobinurie)
|
|
EDTA |
|
71 (3) |
–
|
55164-8
|
—
|
› |
|
2000
|
Dikdruppel controle
Panel
|
|
EDTA |
|
146 (6,1) |
–
|
—
|
—
|
› |
